Lysosomal stress and lipid peroxidation products induce VEGF-121 and VEGF-165 expression in ARPE-19 cells

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 249, Issue 10, 2011, Pages 1477-1483

  Bergmann, Marion ^a   Holz, Frank ^b   Kopitz, Jürgen ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

Age related macular degeneration; Lipid peroxidation; Lysosome; Retinal pigment epithelium; VEGF

Indexed keywords

4 HYDROXYNONENAL; BAFILOMYCIN; ISOPROTEIN; MALONALDEHYDE; MESSENGER RNA; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN 121; VASCULOTROPIN 165; VASCULOTROPIN 189; VASCULOTROPIN 206;

ACIDIFICATION; ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; ISOELECTRIC POINT; LIPID PEROXIDATION; LYSOSOME; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN SECRETION; QUANTITATIVE ANALYSIS; RETINA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 85027926194     PISSN: 0721832X     EISSN: 1435702X     Source Type: Journal    
DOI: 10.1007/s00417-011-1682-0     Document Type: Article

References (26)

1. DT Shima AP Adamis N Ferrara KT Yeo TK Yeo R Allende J Folkman P D'Amore 1995 Hypoxic induction of endothelial cell growth factors in retinal cells: identification and characterization of vascular endothelial growth factor (VEGF) as the mitogen Mol Med 1 182 193 8529097 1:CAS:528:DyaK2MXlt1egsLk%3D
2. K Spilsbury KL Garrett WY Shen IJ Constable PE Rakoczy 2000 Overexpression of vascular endothelial growth factor (VEGF) in the retinal pigment epithelium leads to the development of choroidal neovascularization Am J Pathol 157 135 144 10880384 10.1016/S0002-9440(10)64525-7 1:CAS:528: DC%2BD3cXlsVGmt7w%3D (Pubitemid 30641731)
3. N Eter TU Krohne FG Holz 2006 New pharmacologic approaches to therapy for age-related macular degeneration Biodrugs 20 167 179 16724865 10.2165/00063030-200620030-00004 1:CAS:528:DC%2BD2sXhtV2rtrvI (Pubitemid 43845337)
4. I Zachary 2005 Neuroprotective role of vascular endothelial growth factor: signalling mechanisms, biological function, and therapeutic potential Neurosignals 14 207 221 16301836 10.1159/000088637 1:CAS:528:DC%2BD2MXht1elt7jP (Pubitemid 41661355)
5. A Klettner J Roider 2009 Constitutive and oxidative-stress-induced expression of VEGF in the RPE are differently regulated by different mitogen-activated protein kinases Graefes Arch Clin Exp Ophthalmol 247 1487 1492 19603178 10.1007/s00417-009-1139-x
6. GL Semenza 2003 Angiogenesis in ischemic and neoplastic disorders Ann Rev Med 54 17 28 12359828 10.1146/annurev.med.54.101601.152418 1:CAS:528: DC%2BD3sXit1ejs7o%3D (Pubitemid 37386383)
7. G Martin G Schlunck LL Hansen HT Agostini 2004 Differential expression of angioregulatory factors in normal and CNV-derived human retinal pigment epithelium Graefes Arch Clin Exp Ophthalmol 242 321 326 14722782 10.1007/s00417-003-0838-y 1:CAS:528:DC%2BD2cXjt1Gmtb0%3D (Pubitemid 38647606)
8. CM Sheridan S Pate P Hiscott D Wong M Pattwell D Kent 2009 Expression of hypoxia-inducible factor-1-alpha and 2-alpha in human choroidal neovascular membranes Graefes Arch Clin Exp Ophthalmol 247 1361 136 19590888 10.1007/s00417-009-1133-3 1:CAS:528:DC%2BD1MXhtVeqsb%2FF
9. N Ferrara 2004 Vascular endothelial growth factor: basic science and clinical progress Endocr Rev 25 581 611 15294883 10.1210/er.2003-0027 1:CAS:528:DC%2BD2cXns1Ght74%3D (Pubitemid 39099316)
10. P Ben Av LJ Crofford RL Wilder T Hla 1995 Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: a potential mechanism for inflammatory angiogenesis FEBS Lett 372 83 87 7556649 10.1016/0014-5793(95)00956-A 1:CAS:528:DyaK2MXosVOit74%3D
11. T Cohen D Nahari LW Cerem G Neufeld BZ Levi 1996 Interleukin 6 induces the expression of vascular endothelial growth factor J Biol Chem 271 736 741 8557680 10.1074/jbc.271.2.736 1:STN:280:DyaK287jt1yjsw%3D%3D (Pubitemid 26034921)
12. 2, vascular endothelial growth factor and receptors in the retina of the BBZ/Wor diabetic rat Free Radic Biol Med 28 91 101 10656295 10.1016/S0891-5849(99)00216-6 1:CAS:528:DC%2BD3cXhtVaitrs%3D (Pubitemid 30045577)
13. R Kannan N Zhang PG Sreekumar CK Spee A Rodriguez E Barron DR Hinton 2006 Stimulation of apical and basolateral VEGF-A and VEGF-C secretion by oxidative stress in polarized retinal pigment epithelial cells Mol Vis 12 1649 1659 17200665 1:CAS:528:DC%2BD2sXjsVentQ%3D%3D (Pubitemid 46050311)
14. J Kopitz FG Holz E Kaemmerer F Schutt 2004 Lipids and lipid peroxidation products in the pathogenesis of age-related macular degeneration Biochimie 86 825 831 15589692 10.1016/j.biochi.2004.09.029 1:CAS:528:DC%2BD2cXhtVKksLbE (Pubitemid 39602762)
15. J Zhou B Cai YP Jang S Pachydaki AM Schmidt JR Sparrow 2005 Mechanisms for the induction of HNE- MDA- and AGE-adducts. RAGE and VEGF in retinal pigment epithelial cells Exp Eye Res 80 567 580 15781285 10.1016/j.exer.2004.11.009 1:CAS:528:DC%2BD2MXisVCmtLo%3D (Pubitemid 40387526)
16. FG Holz F Schutt J Kopitz GE Eldred FE Kruse HE Volcker M Cantz 1999 Inhibition of lysosomal degradative functions in RPE cells by a retinoid component of lipofuscin Invest Ophthalmol Vis Sci 40 737 743 10067978 1:STN:280:DyaK1M7msFejsw%3D%3D (Pubitemid 29109453)
17. M Bergmann F Schutt FG Holz J Kopitz 2004 Inhibition of the ATP-driven proton pump in RPE lysosomes by the major lipofuscin fluorophore A2-E may contribute to the pathogenesis of age-related macular degeneration FASEB J 18 562 564 14715704 1:CAS:528:DC%2BD2cXisVygsr4%3D
18. FM Gabhann AS Popel 2008 Systems biology of vascular endothelial growth factors Microcirculation 15 715 738 10.1080/10739680802095964
19. BA Keyt LT Berleau HV Nguyen H Chen H Heinsohn R Vandlen N Ferrara 1996 The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency J Biol Chem 271 7788 7795 8631822 10.1074/jbc.271.13.7788 1:CAS:528:DyaK28XhvFyktLw%3D (Pubitemid 26111064)
20. S Lee SM Jilani GV Nikolova D Carpizo ML Iruela-Arispe 2005 Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors J Cell Biol 169 681 691 15911882 10.1083/jcb.200409115 1:CAS:528:DC%2BD2MXksFyqsLk%3D (Pubitemid 41002860)
21. I Zachary 2005 Signal transduction in angiogenesis EXS 94 267 300 15617484
22. AK Olsson A Dimberg J Kreuger L Claesson-Welsh 2006 VEGF receptor signalling - in control of vascular function Nat Rev Mol Cell Biol 7 359 371 16633338 10.1038/nrm1911 1:CAS:528:DC%2BD28XjslSktrc%3D
23. CL Helm ME Fleury AH Zisch F Boschetti MA Swartz 2005 Synergy between interstitial flow and VEGF directs capillary morphogenesis in vitro through a gradient amplification mechanism Proc Natl Acad Sci USA 102 15779 15784 16249343 10.1073/pnas.0503681102 1:CAS:528:DC%2BD2MXht1Wru7jF (Pubitemid 41552819)
24. K Vlachtsis J Brieger DW Kim R Gieringer J Hast JG Hengstler W Mann 2002 Quantitative analysis of VEGF-isoforms in head and neck squamous cell carcinoma cell lines: relation to xenotransplantability and tumour progression in mice Oncol Rep 9 1133 1138 12168085 1:CAS:528:DC%2BD38XmvVensrw%3D
25. A Grutzkau S Kruger-Krasagakes H Baumeister C Schwarz H Kogel P Welker U Lippert BM Henz A Moller 1998 Synthesis, storage, and release of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) by human mast cells: implications for the biological significance of VEGF206 Mol Biol Cell 9 875 884 9529385 1:CAS:528:DyaK1cXisFSnt7s%3D (Pubitemid 28173640)
26. FG Holz D Pauleikhoff R Klein AC Bird 2004 Pathogenesis of lesions in late age-related macular disease Am J Ophthalmol 137 504 510 15013875 10.1016/j.ajo.2003.11.026 (Pubitemid 38328643)